Stratification of Systemic Lupus Erythematosus Patients Using Gene
  Expression Data to Reveal Expression of Distinct Immune Pathways
  Systemic lupus erythematosus (SLE) is the tenth leading cause of death in
females 15-24 years old in the US. The diversity of symptoms and immune
pathways expressed in SLE patients causes difficulties in treating SLE as well
as in new clinical trials. This study used unsupervised learning on gene
expression data from adult SLE patients to separate patients into clusters. The
dimensionality of the gene expression data was reduced by three separate
methods (PCA, UMAP, and a simple linear autoencoder) and the results from each
of these methods were used to separate patients into six clusters with k-means
clustering.
  The clusters revealed three separate immune pathways in the SLE patients that
caused SLE. These pathways were: (1) high interferon levels, (2) high
autoantibody levels, and (3) dysregulation of the mitochondrial apoptosis
pathway. The first two pathways have been extensively studied in SLE. However,
mitochondrial apoptosis has not been investigated before to the best of our
knowledge as a standalone cause of SLE, independent of autoantibody production,
indicating that mitochondrial proteins could lead to a new set of therapeutic
targets for SLE in future research.
